Theriva Biologics
TOVX • AMEX
Theriva Biologics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Steven A. Shallcross, with a market cap of $15.5M.
Market Cap$15.5M
Employees22.0
CEOSteven A. Shallcross
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 19, 2026 · In 3 weeksBefore Market Open · Q1 2026
Financials
Theriva Biologics FAQ
Common questions about Theriva Biologics
Theriva Biologics is scheduled to report earnings for Q1 2026 on May 19, 2026 before market open.
Theriva Biologics has approximately 22 employees.